Effects of Intensive Therapy and Antecedent Hypoglycemia on Counterregulatory Responses to Hypoglycemia in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—The physiology of counterregulatory responses during hypoglycemia in intensively treated type 2 diabetic subjects is largely unknown. Therefore, the specific aims of the study tested the hypothesis that 1) 6 months of intensive therapy to lower A1C <7.0% would blunt autonomic nervous system (ANS) responses to hypoglycemia, and 2) antecedent hypoglycemia will result in counterregulatory failure during subsequent hypoglycemia in patients with suboptimal and good glycemic control. RESEARCH DESIGN AND METHODS—Fifteen type 2 diabetic patients (8 men/7 women) underwent 6-month combination therapy of metformin, glipizide XL, and acarbose to lower A1C to 6.7% and 2-day repeated hypoglycemic clamp studies before and after intensive therapy. A control group of eight nondiabetic subjects participated in a single 2-day repeated hypoglycemic clamp study. RESULTS—Six-month therapy reduced A1C from 10.2 ± 0.5 to 6.7 ± 0.3%. Rates of hypoglycemia increased to 3.2 episodes per patient/month by study end. Hypoglycemia (3.3 ± 0.1 mmol/l) and insulinemia (1,722 ± 198 pmol/l) were similar during all clamp studies. Intensive therapy reduced (P < 0.05) ANS and metabolic counterregulatory responses during hypoglycemia. Antecedent hypoglycemia produced widespread blunting (P < 0.05) of neuroendocrine, ANS, and metabolic counterregulatory responses during subsequent hypoglycemia before and after intensive therapy in type 2 diabetic patients and in nondiabetic control subjects. CONCLUSIONS—Intensive oral combination therapy and antecedent hypoglycemia both blunt physiological defenses against subsequent hypoglycemia in type 2 diabetes. Prior hypoglycemia of only 3.3 ± 0.1 mmol/l can result in counterregulatory failure in type 2 diabetic patients with suboptimal control and can further impair physiological defenses against hypoglycemia in intensively treated type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recurrent hypoglycemia may impair the individual's ability to sense subsequent hypoglycemia (54,55).”
From Hypoglycemia (2018) · cites this paper as [54]
In the citing paper
“Consistent with the attenuation of sympathoadrenal function after antecedent hypoglycemia, however, antecedent hypoglycemia attenuates the MSNA response to subsequent hypoglycemia (Davis et al., 2009).”
From Stress, hypoglycemia, and the autonomic nervous system (2022) · cites this paper as Davis et al., 2009
In the citing paper
“The vascular sympathetic component of the baroreflex, i.e., MSNA, increases during hypoglycemia (Hoffman et al., 1994; Davis et al., 2009).”
From Stress, hypoglycemia, and the autonomic nervous system (2022) · cites this paper as Davis et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
THE PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY
GREENWOOD, F., HUNTER, W., & GLOVER, J. (1963) · Biochemical Journal · doi:10.1042/bj0890114 · Cited by 10,152
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity
HUNTER, W. M., & GREENWOOD, F. C. (1962) · Nature · doi:10.1038/194495a0 · Cited by 6,919
Standards of Medical Care in Diabetes—2008
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s012 · Cited by 1,377
Gerstein, H. C., Miller, M., & Byington, R. P. (2010) · Cited by 981
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Hypoglycemia in the Diabetes Control and Complications Trial
The Diabetes Control and Complications Trial Research Group (1997) · Diabetes · doi:10.2337/diab.46.2.271 · Cited by 746
Lloyd, B., Burrin, J., Smythe, P., & Alberti, K. G. (1978) · Clinical Chemistry · doi:10.1093/clinchem/24.10.1724 · Cited by 579
Abumrad, N. N., Rabin, D., Diamond, M. P., & Lacy, W. W. (1981) · Metabolism · doi:10.1016/0026-0495(81)90074-3 · Cited by 567
Radioimmunoassay of proteins with the use of Sephadex-coupled antibodies
Wide, L., & Porath, J. (1966) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(66)90032-8 · Cited by 552
Pancreatic Glucagon Secretion in Normal and Diabetic Subjects
Aguilar-Parada, E., Eisentraut, A. M., & Unger, R. H. (1969) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196906000-00008 · Cited by 535
Nunnelee, J. D. (2008) · Journal of Vascular Nursing · doi:10.1016/j.jvn.2008.08.002 · Cited by 407
Radiochemical assay of long-chain fatty acids using 63Ni as tracer
Ho, R. J. (1970) · Analytical Biochemistry · doi:10.1016/0003-2697(70)90337-4 · Cited by 377
Hypoglycemia-associated autonomic failure in advanced type 2 diabetes.
Segel, S. A., Paramore, D. S., & Cryer, P. E. (2002) · Diabetes · doi:10.2337/diabetes.51.3.724 · Cited by 337 · cited 3×
“However, similar to some (13,16) but not all studies (17), there was no difference in values of the key counterregulatory hormones, epinephrine and glucagon, during hypoglycemia when compared with nondiabetic control subjects.”
Islet Inflammation in Type 2 Diabetes
Donath, M. Y., Schumann, D. M., Faulenbach, M., Ellingsgaard, H., Perren, A., & Ehses, J. A. (2008) · Diabetes Care · doi:10.2337/dc08-s243 · Cited by 334
Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man
WALLIN, B. G., SUNDLÖF, G., ERIKSSON, B., DOMINIAK, P., GROBECKER, H., & LINDBLAD, L. E. (1981) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1981.tb06706.x · Cited by 316
Amiel, S. A., Tamborlane, W. V., Simonson, D. C., & Sherwin, R. S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705283162205 · Cited by 309
Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis
Deary, I. J., Hepburn, D. A., MacLeod, K. M., & Frier, B. M. (1993) · Diabetologia · doi:10.1007/bf00401150 · Cited by 286
Gerstein, H. C., Pogue, J., Mann, J. F. E., Lonn, E., Dagenais, G. R., McQueen, M., Yusuf, S., & HOPE investigators (2005) · Diabetologia · doi:10.1007/s00125-005-1858-4 · Cited by 262
(1991) · PubMed · Cited by 245
Effect of Insulin on Utilization and Production of Circulating Glucose
Wall, J. S., Steele, R., de Bodo, R. C., & Altszuler, N. (1957) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1957.189.1.43 · Cited by 180
Hypoglycemia in Type 1 and Type 2 Diabetes: Physiology, Pathophysiology,and Management
Briscoe, V. J., & Davis, S. N. (2006) · Clinical Diabetes · doi:10.2337/diaclin.24.3.115 · Cited by 174
Self-citationAssay of plasma catecholamines by liquid chromatography with electrochemical detection
Causon, R. C., Carruthers, M. E., & Rodnight, R. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90347-x · Cited by 159
Spyer, G., Hattersley, A. T., MacDonald, I., Amiel, S., & MacLeod, K. M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03322-5 · Cited by 126
Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM.
Davis, M. R., Mellman, M., & Shamoon, H. (1992) · Diabetes · doi:10.2337/diab.41.10.1335 · Cited by 98
Effect of Glycemic Control on Glucose Counterregulation During Hypoglycemia in NIDDM
Levy, C. J., Kinsley, B. T., Bajaj, M., & Simonson, D. C. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1330 · Cited by 81
Estrogen Blunts Neuroendocrine and Metabolic Responses to Hypoglycemia
Sandoval, D. A., Ertl, A. C., Richardson, M. A., Tate, D. B., & Davis, S. N. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1749 · Cited by 75
Self-citationEffects of Glycemic Control on Protective Responses Against Hypoglycemia in Type 2 Diabetes
Korzon-Burakowska, A., Hopkins, D., Matyka, K., Lomas, J., Pernet, A., Macdonald, I., & Amiel, S. (1998) · Diabetes Care · doi:10.2337/diacare.21.2.283 · Cited by 71
Glycemic Control Determines Hepatic and Peripheral Glucose Effectiveness in Type 2 Diabetic Subjects
Hawkins, M., Gabriely, I., Wozniak, R., Reddy, K., Rossetti, L., & Shamoon, H. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2179 · Cited by 67
Hypoglycemia in diabetes: common, often unrecognized.
Gabriely, I., & Shamoon, H. (2004) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.71.4.335 · Cited by 58
Predominance of renal and absence of hepatic metabolism of pancreatic polypeptide in the dog
Hagopian, W., Lever, E. G., Cohen, D., Emmanouel, D., Polonsky, K. S., Pugh, W., Moossa, A., & Jaspan, J. B. (1983) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1983.245.2.e171 · Cited by 54
Yudkin, J. S. (2006) · Diabetologia · doi:10.1007/s00125-005-0115-1 · Cited by 40
Multiple defects in counterregulation of hypoglycemia in modestly advanced type 2 diabetes mellitus
Israelian, Z., Szoke, E., Woerle, J., Bokhari, S. M. N. A., Schorr, M., Schwenke, D. C., Cryer, P. E., Gerich, J. E., & Meyer, C. (2006) · Metabolism · doi:10.1016/j.metabol.2005.11.013 · Cited by 34
Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM
Davis, M. R., Mellman, M. J., & Shamoon, H. (1992) · Diabetes · doi:10.2337/diabetes.41.10.1335 · Cited by 31
Burge, M. R., Sobhy, T. A., Qualls, C. R., & Schade, D. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.7993 · Cited by 17
Cited by
Hypoglycemia: The neglected complication
Kalra, S., Mukherjee, J. J., Venkataraman, S., Bantwal, G., Shaikh, S., Saboo, B., Das, A. K., & Ramachandran, A. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.117219 · Cited by 255
Neuroendocrine responses to hypoglycemia
Tesfaye, N., & Seaquist, E. R. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05820.x · Cited by 164
The importance of hypoglycemia in diabetic patients
Shafiee, G., Mohajeri-Tehrani, M., Pajouhi, M., & Larijani, B. (2012) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-11-17 · Cited by 163
Exercise therapy in Type 2 diabetes
Praet, S. F. E., & van Loon, L. J. C. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0129-0 · Cited by 128
Impaired awareness of hypoglycaemia: a review
Graveling, A. J., & Frier, B. M. (2010) · Diabetes & Metabolism · doi:10.1016/s1262-3636(10)70470-5 · Cited by 160
Metadata
- Authors
- Davis, S. N., Mann, S., Briscoe, V. J., Ertl, A. C., & Tate, D. B.
- Affiliations
- Vanderbilt University (US)
- ORCID
- Davis, Stephen N.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-03-01
- Volume
- 58
- Issue
- 3
- Pages
- 701-709
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2646069
- OpenAlex
- W2137066860
- Cited by
- 74
- References
- 39
- Citations by year
- 2026: 2 · 2024: 3 · 2023: 2 · 2022: 5 · 2021: 4 · 2019: 1 · 2018: 5 · 2017: 2 · 2016: 6 · 2015: 4 · 2014: 4 · 2013: 11 · 2012: 4
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Vanderbilt University
- Deutsches Krebsforschungszentrum
- National Institutes of Health (5p60dk020593-31, DK-020593)
- National Heart, Lung, and Blood Institute (P01HL056693)
- National Institute of Diabetes and Digestive and Kidney Diseases (P60-DK020593, R01DK069803)
- National Center for Research Resources (M01RR000095, MO1-RR-000095)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 2 diabetes, hypoglycemia, counterregulatory response, tight glycemic control, autonomic nervous system, hypoglycemic clamp, insulin levels, metformin, glipizide, acarbose, glycemic variability
- MeSH terms
- Autonomic Nervous System, Blood Glucose, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Fatty Acids, Nonesterified, Glucose, Glycerol, Glycated Hemoglobin, Homeostasis, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Lactates, Neurosecretory Systems, Glucose Clamp Technique
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.